Enveric Biosciences Valuation
| ENVB Stock | USD 1.74 0.01 0.58% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Enveric Biosciences shows a prevailing Real Value of $3.41 per share. The current price of the firm is $1.74. Our model computes the value of Enveric Biosciences from reviewing the firm fundamentals such as Shares Owned By Insiders of 0.06 %, shares owned by institutions of 7.16 %, and Current Valuation of (3.75 M) as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Enveric Biosciences' valuation include:
Price Book 0.8415 | Enterprise Value | Enterprise Value Ebitda 0.2891 | Price Sales 0.0831 | Forward PE 23.0947 |
Undervalued
Today
Please note that Enveric Biosciences' price fluctuation is extremely dangerous at this time. Calculation of the real value of Enveric Biosciences is based on 3 months time horizon. Increasing Enveric Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Enveric Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enveric Stock. However, Enveric Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.74 | Real 3.41 | Target 8.5 | Hype 1.75 | Naive 0.85 |
The real value of Enveric Stock, also known as its intrinsic value, is the underlying worth of Enveric Biosciences Company, which is reflected in its stock price. It is based on Enveric Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Enveric Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Enveric Biosciences helps investors to forecast how Enveric stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enveric Biosciences more accurately as focusing exclusively on Enveric Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Enveric Biosciences' intrinsic value based on its ongoing forecasts of Enveric Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Enveric Biosciences' closest peers. If more than one evaluation category is relevant for Enveric Biosciences we suggest using both methods to arrive at a better estimate.
Enveric Biosciences Cash |
|
Enveric Valuation Trend
Comparing Enveric Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Enveric Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Enveric Biosciences Total Value Analysis
Enveric Biosciences is currently anticipated to have valuation of (3.75 M) with market capitalization of 3.5 M, debt of 2.34 M, and cash on hands of 18.01 M. The negative valuation of Enveric Biosciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Enveric Biosciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.75 M) | 3.5 M | 2.34 M | 18.01 M |
Enveric Biosciences Asset Utilization
One of the ways to look at asset utilization of Enveric is to check how much profit was generated for every dollar of assets it reports. Enveric Biosciences shows a negative utilization of assets of -0.97 percent, losing $0.009688 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Enveric Biosciences shows how discouraging it operates for each dollar spent on its assets.Enveric Biosciences Ownership Allocation
Roughly 92.78 percent of Enveric Biosciences outstanding shares are held by general public with 0.06 (percent) owned by insiders and only 7.16 % by other corporate entities.Enveric Biosciences Profitability Analysis
Net Loss for the year was (17.29 M) with profit before overhead, payroll, taxes, and interest of 8.15 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Enveric Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Enveric Biosciences and how it compares across the competition.
About Enveric Biosciences Valuation
The stock valuation mechanism determines Enveric Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Enveric Biosciences. We calculate exposure to Enveric Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Enveric Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -469.2 K | -445.8 K | |
| Pretax Profit Margin | (0.13) | (0.12) | |
| Operating Profit Margin | (0.14) | (0.15) | |
| Net Loss | (0.14) | (0.13) | |
| Gross Profit Margin | 0.23 | 0.22 |
Enveric Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.2 M | |
| Forward Price Earnings | 23.0947 |
Enveric Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Enveric Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Enveric we look at many different elements of the entity such as Enveric's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Enveric Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Enveric Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Enveric Biosciences' worth.Complementary Tools for Enveric Stock analysis
When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |